Brief: Lee's Pharmaceutical Says Got NMPA Approval For IND Application Of GCC-4401C
11/03/2021 15:32
March 11 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* GETS NMPA APPROVAL FOR IND APPLICATION OF GCC-4401C
* APPROVAL TO CONDUCT TRIALS FOR GCC-4401C AS POTENTIAL
TREATMENT
FOR CIRRHOTIC PATIENTS WITH NON-TUMORAL PORTAL VEIN THROMBOSIS
Source text for Eikon: urn:newsml:reuters.com:*:nHKS7bSpSl
Further company coverage: 0950.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA